I agree that this site is using cookies. You can find further informations here.
X
Peswani, Shilpa
14  results:
Search for persons X
?
1

Leverage constraints or preference for lottery: What explai..:

Peswani, Shilpa ; Joshipura, Mayank
Investment Management and Financial Innovations.  18 (2021)  2 - p. 48-63 , 2021
Link: https://doi.org/10.21511..
 
?
2

Leverage Constraints or Preference for Lottery: What Explai..:

Peswani, Shilpa ; Joshipura, Mayank
Shilpa Peswani and Mayank Joshipura (2021). Leverage constraints or preference for lottery: What explains the low-risk effect in India?. Investment Management and Financial Innovations, 18(2), 48-63. doi:10.21511/imfi.18(2).2021.05.  , 2021
Link: https://ssrn.com/abstrac..
 
?
3

The Volatility Effect Across Size Buckets: Evidence From th..:

Peswani, Shilpa ; Joshipura, Mayank
Shilpa Peswani and Mayank Joshipura (2019). The volatility effect across size buckets: evidence from the Indian stock market. Investment Management and Financial Innovations, 16(3), 62-75. doi:10.21511/imfi.16(3).2019.07.  , 2019
Link: https://ssrn.com/abstrac..
 
?
4

The volatility effect across size buckets: evidence from th..:

Peswani, Shilpa ; Joshipura, Mayank
Investment Management and Financial Innovations.  16 (2019)  3 - p. 62-75 , 2019
Link: https://doi.org/10.21511..
 
?
5

Returns to Low Risk Investment Strategy:

Peswani, Shilpa Girish
Applied Finance Letters.  6 (2017)  1 - p. 2-15 , 2017
Link: https://doi.org/10.24135..
 
?
6

Exosome-based therapies for mucosal delivery:

Peswani Sajnani, Shilpa Lekhraj ; Zhang, Yunyue ; Vllasaliu, Driton
International Journal of Pharmaceutics.  608 (2021)  - p. 121087 , 2021
Link: https://doi.org/10.1016/..
 
?
7

Returns to Low Risk Investment Strategy:

Peswani, Shilpa Girish
https://ojs.aut.ac.nz/applied-finance-letters/article/view/65/63.  , 2017
Link: https://ojs.aut.ac.nz/ap..
 
?
8

KCL TEST: an open-source inspired asymptomatic SARS-CoV-2 s..:

Reis de Andrade, Joana ; Scourfield, Edward ; Peswani-Sajnani, Shilpa Lekhraj...
Biology Methods and Protocols.  9 (2024)  1 - p. , 2024
Link: https://doi.org/10.1093/..
 
?
9

Leverage constraints or preference for lottery: What explai..:

Shilpa Peswani ; Mayank Joshipura
https://businessperspectives.org/images/pdf/applications/publishing/templates/article/assets/14923/IMFI_2021_02_Peswani.pdf.  , 2021
Link: https://doi.org/10.21511..
 
?
10

The volatility effect across size buckets: evidence from th..:

Shilpa Peswani ; Mayank Joshipura
https://businessperspectives.org/images/pdf/applications/publishing/templates/article/assets/12360/IMFI_2019_03_Peswani.pdf.  , 2019
Link: https://doi.org/10.21511..
 
?
11

Exosome-based therapies for mucosal delivery:

Peswani Sajnani, Shilpa Lekhraj ; Zhang, Yunyue ; Vllasaliu, Driton
Peswani Sajnani , S L , Zhang , Y & Vllasaliu , D 2021 , ' Exosome-based therapies for mucosal delivery ' , INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol. 608 , 121087 . https://doi.org/10.1016/j.ijpharm.2021.121087.  , 2021
Link: https://kclpure.kcl.ac.u..
 
?
12

Exosome-based therapies for mucosal delivery:

Peswani Sajnani, Shilpa Lekhraj ; Zhang, Yunyue ; Vllasaliu, Driton
Peswani Sajnani , S L , Zhang , Y & Vllasaliu , D 2021 , ' Exosome-based therapies for mucosal delivery ' , INTERNATIONAL JOURNAL OF PHARMACEUTICS , vol. 608 , 121087 . https://doi.org/10.1016/j.ijpharm.2021.121087.  , 2021
Link: https://kclpure.kcl.ac.u..
 
?
13

Herramientas moleculares para el desarrollo de tratamientos..:

Peswani Sajnani, Shilpa Lekhraj
https://hdl.handle.net/20.500.14352/20866.  , 2017
Link: https://hdl.handle.net/2..
 
?
14

Returns to Low Risk Investment Strategy:

Shilpa Girish Peswani
https://ojs.aut.ac.nz/applied-finance-letters/article/view/65.  , 2017
Link: https://doi.org/10.24135..
 
1-14